Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk

The variability in DNA repair capacity of the general population may depend in part upon common variants in DNA repair genes. X-ray repair cross complementing group 1 ( XRCC1 ) is an important DNA base excision repair gene and exhibits polymorphic variation. Using the Long Island Breast Cancer Study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2005-02, Vol.14 (2), p.336-342
Hauptverfasser: JING SHEN, GAMMON, Marilie D, NEUGUT, Alfred I, SANTELLA, Regina M, TERRY, Mary Beth, LIANWEN WANG, QIAO WANG, FANGFANG ZHANG, TEITELBAUM, Susan L, ENG, Sybil M, SAGIV, Sharon K, GAUDET, Mia M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 342
container_issue 2
container_start_page 336
container_title Cancer epidemiology, biomarkers & prevention
container_volume 14
creator JING SHEN
GAMMON, Marilie D
NEUGUT, Alfred I
SANTELLA, Regina M
TERRY, Mary Beth
LIANWEN WANG
QIAO WANG
FANGFANG ZHANG
TEITELBAUM, Susan L
ENG, Sybil M
SAGIV, Sharon K
GAUDET, Mia M
description The variability in DNA repair capacity of the general population may depend in part upon common variants in DNA repair genes. X-ray repair cross complementing group 1 ( XRCC1 ) is an important DNA base excision repair gene and exhibits polymorphic variation. Using the Long Island Breast Cancer Study Project, a population-based case-control study, we evaluated the hypothesis that two common single nucleotide polymorphisms of XRCC1 (codon 194 Arg→Trp and 399 Arg→Gln) influence breast cancer susceptibility and interact with polycyclic aromatic hydrocarbon (PAH)-DNA adducts, cigarette smoking, and intake of fruits and vegetables and antioxidants. The available sample for genotyping included 1,067 cases and 1,110 controls. Genotyping was done by a high-throughput single-nucleotide extension assay with fluorescence polarization detection of the incorporated nucleotide. We observed no significant increases in risk among all subjects who were carriers of XRCC1 194Trp or 399Gln alleles. Among never smokers, we observed an increased risk of breast cancer in 399Gln carriers [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.0-1.7). Further analysis indicated a suggestive weak additive interaction between the 399Gln allele and detectable PAH-DNA adducts (OR for exposure with mutant genotype, 1.9; 95% CI, 1.2-3.1). The estimated age-adjusted interaction contrast ratio (ICR) and 95% CI (ICR, 0.38; 95% CI, −0.32 to 1.10) indicated that the departure from additivity was not statistically significant, but that there was some suggestion of a relative excess risk due to the interaction. In subjects with at least one copy of XRCC1 194Trp allele, there was a moderate interaction with high intake of fruits and vegetables (≥35 half-cup servings per week of any fruits, fruit juices, and vegetables, OR, 0.58; 95% CI, 0.38-0.89; ICR, −0.49; 95% CI, −0.03 to −0.95), and dietary plus supplement antioxidant intake with 33% to 42% decreases in breast cancer risk compared with those with the Arg194Arg genotype and low-intake individuals. These results do not show that the two genetic polymorphisms of XRCC1 independently influence breast cancer risk. However, there is evidence for interactions between the two XRCC1 single nucleotide polymorphisms and PAH-DNA adducts or fruit and vegetable and antioxidant intake on breast cancer risk. Further understanding of the biological function of XRCC1 variants and their interactions with PAH-DNA adducts, antioxidants, and other genes in the pat
doi_str_mv 10.1158/1055-9965.EPI-04-0414
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67460942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17803817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-f8122ba94455da42aee4f6a22ffa8acb619e8adcef5a61ad5a13df01c3e334ce3</originalsourceid><addsrcrecordid>eNqFkc9u1DAQhyMEoqXwCCBfgEtT7PhPkmOatrRSgaqAxM2atSe7pkm82Fm1-zo8KQ67qEckSx7J329Gni_LXjN6wpisPjAqZV7XSp6c31zlVKTDxJPskEle5WUp5dNU_2MOshcx_qSUlrWUz7MDJksuUnmY_b7x_XbwYb1ycYjEjeTHbdsy8slb123JtELSxOiNg8n5kSxwukccyZwyW9M7Q5rgh_RoyOXWBm8gLPyYn31uSGPtxkzxmLRuCQGnCcnXwd-5cXlMzhxOELakGVPbB2dhnEEYLTkNCHEiLYwGA7l18e5l9qyDPuKr_X2Ufb84_9Ze5tdfPl61zXVuhFJT3lWsKBZQCyGlBVEAougUFEXXQQVmoViNFViDnQTFwEpg3HaUGY6cC4P8KHu367sO_tcG46QHFw32PYzoN1GrUihai-K_ICsryitWJlDuQBN8jAE7vQ5uSP_WjOrZop4N6dmQThY1FXq2mHJv9gM2iwHtY2qvLQFv9wBEA30X0rZcfOSUlIoXc6P3O27llqt7F1Cbv3sNGBGCWWkmdKE5V_wPmXS2MQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17803817</pqid></control><display><type>article</type><title>Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>JING SHEN ; GAMMON, Marilie D ; NEUGUT, Alfred I ; SANTELLA, Regina M ; TERRY, Mary Beth ; LIANWEN WANG ; QIAO WANG ; FANGFANG ZHANG ; TEITELBAUM, Susan L ; ENG, Sybil M ; SAGIV, Sharon K ; GAUDET, Mia M</creator><creatorcontrib>JING SHEN ; GAMMON, Marilie D ; NEUGUT, Alfred I ; SANTELLA, Regina M ; TERRY, Mary Beth ; LIANWEN WANG ; QIAO WANG ; FANGFANG ZHANG ; TEITELBAUM, Susan L ; ENG, Sybil M ; SAGIV, Sharon K ; GAUDET, Mia M</creatorcontrib><description>The variability in DNA repair capacity of the general population may depend in part upon common variants in DNA repair genes. X-ray repair cross complementing group 1 ( XRCC1 ) is an important DNA base excision repair gene and exhibits polymorphic variation. Using the Long Island Breast Cancer Study Project, a population-based case-control study, we evaluated the hypothesis that two common single nucleotide polymorphisms of XRCC1 (codon 194 Arg→Trp and 399 Arg→Gln) influence breast cancer susceptibility and interact with polycyclic aromatic hydrocarbon (PAH)-DNA adducts, cigarette smoking, and intake of fruits and vegetables and antioxidants. The available sample for genotyping included 1,067 cases and 1,110 controls. Genotyping was done by a high-throughput single-nucleotide extension assay with fluorescence polarization detection of the incorporated nucleotide. We observed no significant increases in risk among all subjects who were carriers of XRCC1 194Trp or 399Gln alleles. Among never smokers, we observed an increased risk of breast cancer in 399Gln carriers [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.0-1.7). Further analysis indicated a suggestive weak additive interaction between the 399Gln allele and detectable PAH-DNA adducts (OR for exposure with mutant genotype, 1.9; 95% CI, 1.2-3.1). The estimated age-adjusted interaction contrast ratio (ICR) and 95% CI (ICR, 0.38; 95% CI, −0.32 to 1.10) indicated that the departure from additivity was not statistically significant, but that there was some suggestion of a relative excess risk due to the interaction. In subjects with at least one copy of XRCC1 194Trp allele, there was a moderate interaction with high intake of fruits and vegetables (≥35 half-cup servings per week of any fruits, fruit juices, and vegetables, OR, 0.58; 95% CI, 0.38-0.89; ICR, −0.49; 95% CI, −0.03 to −0.95), and dietary plus supplement antioxidant intake with 33% to 42% decreases in breast cancer risk compared with those with the Arg194Arg genotype and low-intake individuals. These results do not show that the two genetic polymorphisms of XRCC1 independently influence breast cancer risk. However, there is evidence for interactions between the two XRCC1 single nucleotide polymorphisms and PAH-DNA adducts or fruit and vegetable and antioxidant intake on breast cancer risk. Further understanding of the biological function of XRCC1 variants and their interactions with PAH-DNA adducts, antioxidants, and other genes in the pathway are needed.</description><identifier>ISSN: 1055-9965</identifier><identifier>EISSN: 1538-7755</identifier><identifier>DOI: 10.1158/1055-9965.EPI-04-0414</identifier><identifier>PMID: 15734955</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adult ; Antioxidants ; Antioxidants - metabolism ; Biological and medical sciences ; Breast Cancer Risk ; Breast Neoplasms - epidemiology ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Case-Control Studies ; Diet ; Dietary Supplements ; DNA Adducts - metabolism ; DNA-Binding Proteins - genetics ; Female ; Genotype ; Gynecology. Andrology. Obstetrics ; Humans ; Long Island ; Mammary gland diseases ; Medical sciences ; Middle Aged ; PAH-DNA adducts ; Polycyclic Aromatic Hydrocarbons - metabolism ; Polymorphism, Single Nucleotide ; Risk Factors ; Smoking - physiopathology ; Tumors ; X-ray Repair Cross Complementing Protein 1 ; XRCC1</subject><ispartof>Cancer epidemiology, biomarkers &amp; prevention, 2005-02, Vol.14 (2), p.336-342</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-f8122ba94455da42aee4f6a22ffa8acb619e8adcef5a61ad5a13df01c3e334ce3</citedby><cites>FETCH-LOGICAL-c466t-f8122ba94455da42aee4f6a22ffa8acb619e8adcef5a61ad5a13df01c3e334ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3356,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16556324$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15734955$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JING SHEN</creatorcontrib><creatorcontrib>GAMMON, Marilie D</creatorcontrib><creatorcontrib>NEUGUT, Alfred I</creatorcontrib><creatorcontrib>SANTELLA, Regina M</creatorcontrib><creatorcontrib>TERRY, Mary Beth</creatorcontrib><creatorcontrib>LIANWEN WANG</creatorcontrib><creatorcontrib>QIAO WANG</creatorcontrib><creatorcontrib>FANGFANG ZHANG</creatorcontrib><creatorcontrib>TEITELBAUM, Susan L</creatorcontrib><creatorcontrib>ENG, Sybil M</creatorcontrib><creatorcontrib>SAGIV, Sharon K</creatorcontrib><creatorcontrib>GAUDET, Mia M</creatorcontrib><title>Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk</title><title>Cancer epidemiology, biomarkers &amp; prevention</title><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><description>The variability in DNA repair capacity of the general population may depend in part upon common variants in DNA repair genes. X-ray repair cross complementing group 1 ( XRCC1 ) is an important DNA base excision repair gene and exhibits polymorphic variation. Using the Long Island Breast Cancer Study Project, a population-based case-control study, we evaluated the hypothesis that two common single nucleotide polymorphisms of XRCC1 (codon 194 Arg→Trp and 399 Arg→Gln) influence breast cancer susceptibility and interact with polycyclic aromatic hydrocarbon (PAH)-DNA adducts, cigarette smoking, and intake of fruits and vegetables and antioxidants. The available sample for genotyping included 1,067 cases and 1,110 controls. Genotyping was done by a high-throughput single-nucleotide extension assay with fluorescence polarization detection of the incorporated nucleotide. We observed no significant increases in risk among all subjects who were carriers of XRCC1 194Trp or 399Gln alleles. Among never smokers, we observed an increased risk of breast cancer in 399Gln carriers [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.0-1.7). Further analysis indicated a suggestive weak additive interaction between the 399Gln allele and detectable PAH-DNA adducts (OR for exposure with mutant genotype, 1.9; 95% CI, 1.2-3.1). The estimated age-adjusted interaction contrast ratio (ICR) and 95% CI (ICR, 0.38; 95% CI, −0.32 to 1.10) indicated that the departure from additivity was not statistically significant, but that there was some suggestion of a relative excess risk due to the interaction. In subjects with at least one copy of XRCC1 194Trp allele, there was a moderate interaction with high intake of fruits and vegetables (≥35 half-cup servings per week of any fruits, fruit juices, and vegetables, OR, 0.58; 95% CI, 0.38-0.89; ICR, −0.49; 95% CI, −0.03 to −0.95), and dietary plus supplement antioxidant intake with 33% to 42% decreases in breast cancer risk compared with those with the Arg194Arg genotype and low-intake individuals. These results do not show that the two genetic polymorphisms of XRCC1 independently influence breast cancer risk. However, there is evidence for interactions between the two XRCC1 single nucleotide polymorphisms and PAH-DNA adducts or fruit and vegetable and antioxidant intake on breast cancer risk. Further understanding of the biological function of XRCC1 variants and their interactions with PAH-DNA adducts, antioxidants, and other genes in the pathway are needed.</description><subject>Adult</subject><subject>Antioxidants</subject><subject>Antioxidants - metabolism</subject><subject>Biological and medical sciences</subject><subject>Breast Cancer Risk</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Case-Control Studies</subject><subject>Diet</subject><subject>Dietary Supplements</subject><subject>DNA Adducts - metabolism</subject><subject>DNA-Binding Proteins - genetics</subject><subject>Female</subject><subject>Genotype</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Long Island</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>PAH-DNA adducts</subject><subject>Polycyclic Aromatic Hydrocarbons - metabolism</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Risk Factors</subject><subject>Smoking - physiopathology</subject><subject>Tumors</subject><subject>X-ray Repair Cross Complementing Protein 1</subject><subject>XRCC1</subject><issn>1055-9965</issn><issn>1538-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQhyMEoqXwCCBfgEtT7PhPkmOatrRSgaqAxM2atSe7pkm82Fm1-zo8KQ67qEckSx7J329Gni_LXjN6wpisPjAqZV7XSp6c31zlVKTDxJPskEle5WUp5dNU_2MOshcx_qSUlrWUz7MDJksuUnmY_b7x_XbwYb1ycYjEjeTHbdsy8slb123JtELSxOiNg8n5kSxwukccyZwyW9M7Q5rgh_RoyOXWBm8gLPyYn31uSGPtxkzxmLRuCQGnCcnXwd-5cXlMzhxOELakGVPbB2dhnEEYLTkNCHEiLYwGA7l18e5l9qyDPuKr_X2Ufb84_9Ze5tdfPl61zXVuhFJT3lWsKBZQCyGlBVEAougUFEXXQQVmoViNFViDnQTFwEpg3HaUGY6cC4P8KHu367sO_tcG46QHFw32PYzoN1GrUihai-K_ICsryitWJlDuQBN8jAE7vQ5uSP_WjOrZop4N6dmQThY1FXq2mHJv9gM2iwHtY2qvLQFv9wBEA30X0rZcfOSUlIoXc6P3O27llqt7F1Cbv3sNGBGCWWkmdKE5V_wPmXS2MQ</recordid><startdate>20050201</startdate><enddate>20050201</enddate><creator>JING SHEN</creator><creator>GAMMON, Marilie D</creator><creator>NEUGUT, Alfred I</creator><creator>SANTELLA, Regina M</creator><creator>TERRY, Mary Beth</creator><creator>LIANWEN WANG</creator><creator>QIAO WANG</creator><creator>FANGFANG ZHANG</creator><creator>TEITELBAUM, Susan L</creator><creator>ENG, Sybil M</creator><creator>SAGIV, Sharon K</creator><creator>GAUDET, Mia M</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20050201</creationdate><title>Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk</title><author>JING SHEN ; GAMMON, Marilie D ; NEUGUT, Alfred I ; SANTELLA, Regina M ; TERRY, Mary Beth ; LIANWEN WANG ; QIAO WANG ; FANGFANG ZHANG ; TEITELBAUM, Susan L ; ENG, Sybil M ; SAGIV, Sharon K ; GAUDET, Mia M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-f8122ba94455da42aee4f6a22ffa8acb619e8adcef5a61ad5a13df01c3e334ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Antioxidants</topic><topic>Antioxidants - metabolism</topic><topic>Biological and medical sciences</topic><topic>Breast Cancer Risk</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Case-Control Studies</topic><topic>Diet</topic><topic>Dietary Supplements</topic><topic>DNA Adducts - metabolism</topic><topic>DNA-Binding Proteins - genetics</topic><topic>Female</topic><topic>Genotype</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Long Island</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>PAH-DNA adducts</topic><topic>Polycyclic Aromatic Hydrocarbons - metabolism</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Risk Factors</topic><topic>Smoking - physiopathology</topic><topic>Tumors</topic><topic>X-ray Repair Cross Complementing Protein 1</topic><topic>XRCC1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JING SHEN</creatorcontrib><creatorcontrib>GAMMON, Marilie D</creatorcontrib><creatorcontrib>NEUGUT, Alfred I</creatorcontrib><creatorcontrib>SANTELLA, Regina M</creatorcontrib><creatorcontrib>TERRY, Mary Beth</creatorcontrib><creatorcontrib>LIANWEN WANG</creatorcontrib><creatorcontrib>QIAO WANG</creatorcontrib><creatorcontrib>FANGFANG ZHANG</creatorcontrib><creatorcontrib>TEITELBAUM, Susan L</creatorcontrib><creatorcontrib>ENG, Sybil M</creatorcontrib><creatorcontrib>SAGIV, Sharon K</creatorcontrib><creatorcontrib>GAUDET, Mia M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JING SHEN</au><au>GAMMON, Marilie D</au><au>NEUGUT, Alfred I</au><au>SANTELLA, Regina M</au><au>TERRY, Mary Beth</au><au>LIANWEN WANG</au><au>QIAO WANG</au><au>FANGFANG ZHANG</au><au>TEITELBAUM, Susan L</au><au>ENG, Sybil M</au><au>SAGIV, Sharon K</au><au>GAUDET, Mia M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk</atitle><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><date>2005-02-01</date><risdate>2005</risdate><volume>14</volume><issue>2</issue><spage>336</spage><epage>342</epage><pages>336-342</pages><issn>1055-9965</issn><eissn>1538-7755</eissn><abstract>The variability in DNA repair capacity of the general population may depend in part upon common variants in DNA repair genes. X-ray repair cross complementing group 1 ( XRCC1 ) is an important DNA base excision repair gene and exhibits polymorphic variation. Using the Long Island Breast Cancer Study Project, a population-based case-control study, we evaluated the hypothesis that two common single nucleotide polymorphisms of XRCC1 (codon 194 Arg→Trp and 399 Arg→Gln) influence breast cancer susceptibility and interact with polycyclic aromatic hydrocarbon (PAH)-DNA adducts, cigarette smoking, and intake of fruits and vegetables and antioxidants. The available sample for genotyping included 1,067 cases and 1,110 controls. Genotyping was done by a high-throughput single-nucleotide extension assay with fluorescence polarization detection of the incorporated nucleotide. We observed no significant increases in risk among all subjects who were carriers of XRCC1 194Trp or 399Gln alleles. Among never smokers, we observed an increased risk of breast cancer in 399Gln carriers [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.0-1.7). Further analysis indicated a suggestive weak additive interaction between the 399Gln allele and detectable PAH-DNA adducts (OR for exposure with mutant genotype, 1.9; 95% CI, 1.2-3.1). The estimated age-adjusted interaction contrast ratio (ICR) and 95% CI (ICR, 0.38; 95% CI, −0.32 to 1.10) indicated that the departure from additivity was not statistically significant, but that there was some suggestion of a relative excess risk due to the interaction. In subjects with at least one copy of XRCC1 194Trp allele, there was a moderate interaction with high intake of fruits and vegetables (≥35 half-cup servings per week of any fruits, fruit juices, and vegetables, OR, 0.58; 95% CI, 0.38-0.89; ICR, −0.49; 95% CI, −0.03 to −0.95), and dietary plus supplement antioxidant intake with 33% to 42% decreases in breast cancer risk compared with those with the Arg194Arg genotype and low-intake individuals. These results do not show that the two genetic polymorphisms of XRCC1 independently influence breast cancer risk. However, there is evidence for interactions between the two XRCC1 single nucleotide polymorphisms and PAH-DNA adducts or fruit and vegetable and antioxidant intake on breast cancer risk. Further understanding of the biological function of XRCC1 variants and their interactions with PAH-DNA adducts, antioxidants, and other genes in the pathway are needed.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15734955</pmid><doi>10.1158/1055-9965.EPI-04-0414</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1055-9965
ispartof Cancer epidemiology, biomarkers & prevention, 2005-02, Vol.14 (2), p.336-342
issn 1055-9965
1538-7755
language eng
recordid cdi_proquest_miscellaneous_67460942
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Adult
Antioxidants
Antioxidants - metabolism
Biological and medical sciences
Breast Cancer Risk
Breast Neoplasms - epidemiology
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Case-Control Studies
Diet
Dietary Supplements
DNA Adducts - metabolism
DNA-Binding Proteins - genetics
Female
Genotype
Gynecology. Andrology. Obstetrics
Humans
Long Island
Mammary gland diseases
Medical sciences
Middle Aged
PAH-DNA adducts
Polycyclic Aromatic Hydrocarbons - metabolism
Polymorphism, Single Nucleotide
Risk Factors
Smoking - physiopathology
Tumors
X-ray Repair Cross Complementing Protein 1
XRCC1
title Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A05%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polymorphisms%20in%20XRCC1%20Modify%20the%20Association%20between%20Polycyclic%20Aromatic%20Hydrocarbon-DNA%20Adducts,%20Cigarette%20Smoking,%20Dietary%20Antioxidants,%20and%20Breast%20Cancer%20Risk&rft.jtitle=Cancer%20epidemiology,%20biomarkers%20&%20prevention&rft.au=JING%20SHEN&rft.date=2005-02-01&rft.volume=14&rft.issue=2&rft.spage=336&rft.epage=342&rft.pages=336-342&rft.issn=1055-9965&rft.eissn=1538-7755&rft_id=info:doi/10.1158/1055-9965.EPI-04-0414&rft_dat=%3Cproquest_cross%3E17803817%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17803817&rft_id=info:pmid/15734955&rfr_iscdi=true